Company / Operating Cash Flow per Share
AYTU BIOPHARMA, INC Operating Cash Flow per Share History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.32
FY2025
5-year range
-$2.66 / -$0.25
FY2021-FY2025
Trend
-28.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-386.49 in FY2018 to $-0.25 in FY2024.
Based on SEC 10-K filings.
-0.32 in FY2025.
Improved from $-2.66 to $-0.32 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 28.9% year-over-year.
- Peak operating cash flow per share was recorded in FY2024.
- Lowest operating cash flow per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.32 | -28.9% |
| FY2024 | -$0.25 | +90.5% |
| FY2023 | -$2.66 | -153.6% |
| FY2022 | -$1.05 | +49.2% |
| FY2021 | -$2.06 | -27.5% |
| FY2020 | -$1.62 | +99.6% |
| FY2018 | -$386.49 | -422.9% |
| FY2017 | -$73.92 | -724.2% |
| FY2016 | -$8.97 | -968.2% |
| FY2015 | -$0.84 | -1160.4% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026